Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapyKris M. Mahadeo, Sajad Khazal, Hisham Abdel‐Azim et al.|Nature Reviews Clinical Oncology|2018Cited by 236
Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic LymphomaAmber Gibson, Branko Cuglievan, Nicholas J. Short et al.|Cancers|2021Cited by 66
Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancerDristhi Ragoonanan, Kris M. Mahadeo, Sajad Khazal et al.|Nature Reviews Clinical Oncology|2021Cited by 58
Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapiesBranko Cuglievan, Naveen Pemmaraju, Jeremy Connors et al.|Leukemia|2023Cited by 52
Early Results of the Phase I/II Study Investigating the All-Oral Combination of the Menin Inhibitor Revumenib (SNDX-5613) with Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE)Ghayas C. Issa, Hagop M. Kantarjian, Branko Cuglievan et al.|Blood|2023Cited by 46